Skip to main content

Chart: Massachusetts Recreational Marijuana Sales Soar In First Month Despite Obstacles

Massachusetts dispensaries rang up $9.3 million in recreational marijuana sales during the first four weeks of operation, an impressive feat considering only two stores were selling adult-use cannabis during the bulk of this period.

Compared with the first month of rec sales in other states, Massachusetts had lower gross sales but far fewer operating dispensaries than Oregon ($14 million, 320 dispensaries), Colorado ($14.7 million, 59 dispensaries) and Nevada ($27.1 million, 53 dispensaries).

The two Massachusetts dispensaries – Cultivate in Leicester and New England Treatment Access (NETA) in Northampton – took in more than $440,000 on the first day of sales, and the state averaged $2.3 million in sales per week.

Alternative Therapies Group (ATG) opened Dec. 15 in Salem.

Two more dispensaries – Verilife in Wareham and Insa in Easthampton – were approved to commence recreational sales in late December, with several other dispensaries slated for approval in the new year.

Another hurdle for the market: Sales began Nov. 20 – a Tuesday – and were halted that Thursday for Thanksgiving, abbreviating the first week to five days.

The operating dispensaries also took the unique step of limited per-person transactions below the state’s legal 1-ounce purchasing limit to prevent product shortages.

ATG went a step further, requiring adult-use customers to make an appointment to visit the dispensary.

The Marijuana Business Factbook 2018 estimates that Massachusetts has 900,000 to 1.1 million in-state customers.

And, as the first Eastern state to begin legal adult-use sales, Massachusetts is expected to benefit from the region’s population density.

The state is on pace to break $14 million in recreational sales in 2018.

Here’s what else you need to know:

  • Through Dec. 16, Massachusetts sold 234,656 individual units of recreational marijuana products. The state’s Cannabis Control Commission (CCC) defines a unit as an individual product, such as a package of edibles, container of measured marijuana or bottle of lotion.
  • The state has not set caps on the number of recreational facilities allowed. As of Dec. 16, the CCC had received a total of 224 complete applications. Of those, 13 businesses received their final licenses and 11 had commenced operations, including five retailers, two cultivators, two testing laboratories and two product manufacturers.
  • Medical marijuana dispensaries continue to open. While the state has allowed for unlimited recreational businesses, licensing priority is given to experienced medical dispensaries. The Massachusetts Medical Use of Marijuana Program had more than 57,000 active patients and 47 registered dispensaries as of Nov. 30.

Maggie Cowee can be reached at [email protected]

Eli McVey can be reached at [email protected]

Original Article Source: https://mjbizdaily.com/massachusetts-recreational-marijuana-sales-first-month/

Comments

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...